CEO Bob Mauch highlighted a strong quarter with revenue growth of 10% and adjusted diluted EPS growth of 16%. Guidance for the fiscal year has been raised, reflecting robust first-half performance and ...
Providers of temperature-controlled packaging, storage, and shipping capabilities for the biopharmaceutical industry are about to face their potentially finest moment. Though they are used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results